Condition

Tuberculosis, Multidrug Resistant (3)

Extensively Drug-Resistant Tuberculosis (1)

Tuberculosis, Pulmonary (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Archivel Farma S.L. (1)

Karolinska Institutet (1)

Otsuka Pharmaceutical Development & Commercialization, Inc. (1)

Collaborator

Fudan University (1)

London School of Hygiene and Tropical Medicine (1)

University Medical Center Groningen (1)

Intervention

delamanid (1)

matching ruti® placebo (1)

optimized background regimen (obr) (1)

placebo (1)

ruti® therapeutic vaccine (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

tuberculosis, multidrug resistant

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®

Terminated

Tuberculosis, Multidrug Resistant

RUTI® Therapeutic vaccine
Matching RUTI® Placebo

Chernivtsi, Ukraine
+2 more

Jun 30, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide

Completed

Has Results

Tuberculosis, Pulmonary
+2 more

Delamanid
+2 more

San Antonio, Texas
+16 more

Nov 1, 2021

MDR-TB Related to Minimum Inhibitory Concentrations

Completed

Tuberculosis, Multidrug Resistant

Xiamen, Fujian, China

Xiamen Designated TB hospital

Oct 12, 2020